Clinical trials
Diabetes Mellitus, Type 2 trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 10 |
| 2019 | 13 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 19 |
| 2024 | 9 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
| Unknown status | 22 |
| Not yet recruiting | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 16 |
| Novo Nordisk A/S | 10 |
| Ain Shams University | 8 |
| Sanofi | 7 |
| Assiut University | 6 |
| Damanhour University | 6 |
| Tanta University | 5 |
| Alexandria University | 4 |
| Beni-Suef University | 4 |
| Sohag University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 117 |
| Diabetes Mellitus | 22 |
| Non-alcoholic Fatty Liver Disease | 7 |
| Obesity | 6 |
| Hyperglycemia | 5 |
| Insulin Resistance | 5 |
| Diabetic Neuropathies | 4 |
| Hypertension | 4 |
| Inflammation | 4 |
| Coronary Artery Disease | 3 |
Trials
Showing 26 to 50 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.